Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary Hospital

Introduction: Antibiotic use in coronavirus disease 2019 (COVID-19) patients reached 70% during the pandemic, potentially inducing the invasion of multidrug-resistant organisms (MDROs). This study analyzed patients who died from COVID-19 with MDRO coinfections at Dr. Soetomo General Academic Hospita...

Full description

Saved in:
Bibliographic Details
Main Authors: Joedhistira Bayu Firmansyah, Musofa Rusli, Juniastuti, Ratna Septyawati
Format: Article
Language:English
Published: Faculty of Medicine, Universitas Airlangga 2025-07-01
Series:Current Internal Medicine Research and Practice Surabaya Journal
Subjects:
Online Access:https://e-journal.unair.ac.id/CIMRJ/article/view/53649
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849769829860376576
author Joedhistira Bayu Firmansyah
Musofa Rusli
Juniastuti
Ratna Septyawati
author_facet Joedhistira Bayu Firmansyah
Musofa Rusli
Juniastuti
Ratna Septyawati
author_sort Joedhistira Bayu Firmansyah
collection DOAJ
description Introduction: Antibiotic use in coronavirus disease 2019 (COVID-19) patients reached 70% during the pandemic, potentially inducing the invasion of multidrug-resistant organisms (MDROs). This study analyzed patients who died from COVID-19 with MDRO coinfections at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Methods: We conducted a retrospective descriptive study of 120 deceased COVID-19 inpatients from January to December 2021. The inclusion criteria required: (1) positive MDRO cultures from ≥2 specimens, and (2) resistance to ≥1 agent across ≥3 antimicrobial categories. Patients with incomplete records or no antibiotic therapy were excluded. The data were presented using descriptive statistics to characterize patient demographics, microbiological profiles, and antimicrobial resistance patterns. Results: The patients were predominantly male (60%), aged 41–80 years (78.33%), and hospitalized for 8–30 days (53.44%). The microbiological examinations revealed blood cultures as the main specimen source (43.10%), followed by sputum (27.59%), urine (19.40%), pus (7.33%), and cerebrospinal fluid (2.59%). The prevalent isolates varied by specimen type: coagulase-negative staphylococci (51%) in blood, Pseudomonas spp. in pus (17.65%), Klebsiella spp. in sputum (26.69%), and Escherichia coli in urine (37.78%). The cerebrospinal fluid cultures showed an equal distribution of Gram-negative bacilli, Gram-positive bacilli, and Gram-positive cocci (33.33% each). Conclusion: This study characterizes the profiles of fatal COVID-19 cases with MDRO coinfections, demonstrating a predominance of older male patients with prolonged hospitalization. The identified resistance patterns and pathogen distribution, notably coagulase-negative staphylococci in blood, highlight the importance of improved infection surveillance and antibiotic stewardship to minimize the risk of coinfection in the future.   Highlights: 1. While existing studies have examined multidrug-resistant organism (MDRO) coinfections in COVID-19 globally, this work offers a valuable standalone characterization of a high-risk subgroup in Indonesia, where resistance patterns arising from antimicrobial use during the pandemic created unique clinical challenges. 2. This study provides comprehensive data on the mortality of COVID-19 patients with MDRO coinfections at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, enhancing medical personnel's awareness of MDRO bacterial transmission and informing improvements in antibiotic stewardship programs within hospitals.
format Article
id doaj-art-41bf098324164a1a82b45255d6bc79f2
institution DOAJ
issn 2721-544X
language English
publishDate 2025-07-01
publisher Faculty of Medicine, Universitas Airlangga
record_format Article
series Current Internal Medicine Research and Practice Surabaya Journal
spelling doaj-art-41bf098324164a1a82b45255d6bc79f22025-08-20T03:03:16ZengFaculty of Medicine, Universitas AirlanggaCurrent Internal Medicine Research and Practice Surabaya Journal2721-544X2025-07-016211712410.20473/cimrj.v6i2.5364951811Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary HospitalJoedhistira Bayu Firmansyah0https://orcid.org/0009-0009-0601-3818Musofa Rusli1https://orcid.org/0000-0002-4834-2259Juniastuti2https://orcid.org/0000-0002-1437-640XRatna Septyawati3Medical Study Program, Faculty of Medicine, Universitas Airlangga, SurabayaInfectious and Tropical Disease Division, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General Academic Hospital, SurabayaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga; Dr. Soetomo General Academic Hospital, SurabayaMedical Study Program, Faculty of Medicine, Universitas Jember, JemberIntroduction: Antibiotic use in coronavirus disease 2019 (COVID-19) patients reached 70% during the pandemic, potentially inducing the invasion of multidrug-resistant organisms (MDROs). This study analyzed patients who died from COVID-19 with MDRO coinfections at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Methods: We conducted a retrospective descriptive study of 120 deceased COVID-19 inpatients from January to December 2021. The inclusion criteria required: (1) positive MDRO cultures from ≥2 specimens, and (2) resistance to ≥1 agent across ≥3 antimicrobial categories. Patients with incomplete records or no antibiotic therapy were excluded. The data were presented using descriptive statistics to characterize patient demographics, microbiological profiles, and antimicrobial resistance patterns. Results: The patients were predominantly male (60%), aged 41–80 years (78.33%), and hospitalized for 8–30 days (53.44%). The microbiological examinations revealed blood cultures as the main specimen source (43.10%), followed by sputum (27.59%), urine (19.40%), pus (7.33%), and cerebrospinal fluid (2.59%). The prevalent isolates varied by specimen type: coagulase-negative staphylococci (51%) in blood, Pseudomonas spp. in pus (17.65%), Klebsiella spp. in sputum (26.69%), and Escherichia coli in urine (37.78%). The cerebrospinal fluid cultures showed an equal distribution of Gram-negative bacilli, Gram-positive bacilli, and Gram-positive cocci (33.33% each). Conclusion: This study characterizes the profiles of fatal COVID-19 cases with MDRO coinfections, demonstrating a predominance of older male patients with prolonged hospitalization. The identified resistance patterns and pathogen distribution, notably coagulase-negative staphylococci in blood, highlight the importance of improved infection surveillance and antibiotic stewardship to minimize the risk of coinfection in the future.   Highlights: 1. While existing studies have examined multidrug-resistant organism (MDRO) coinfections in COVID-19 globally, this work offers a valuable standalone characterization of a high-risk subgroup in Indonesia, where resistance patterns arising from antimicrobial use during the pandemic created unique clinical challenges. 2. This study provides comprehensive data on the mortality of COVID-19 patients with MDRO coinfections at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, enhancing medical personnel's awareness of MDRO bacterial transmission and informing improvements in antibiotic stewardship programs within hospitals.https://e-journal.unair.ac.id/CIMRJ/article/view/53649coronavirus disease 2019 (covid-19)pneumoniarespiratory tract infectionmultidrug-resistant organisms (mdros)tropical disease
spellingShingle Joedhistira Bayu Firmansyah
Musofa Rusli
Juniastuti
Ratna Septyawati
Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary Hospital
Current Internal Medicine Research and Practice Surabaya Journal
coronavirus disease 2019 (covid-19)
pneumonia
respiratory tract infection
multidrug-resistant organisms (mdros)
tropical disease
title Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary Hospital
title_full Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary Hospital
title_fullStr Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary Hospital
title_full_unstemmed Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary Hospital
title_short Profiles of Deceased Patients with Coronavirus Disease 2019 (COVID-19) and Multidrug-Resistant Bacterial Coinfections at an Indonesian Tertiary Hospital
title_sort profiles of deceased patients with coronavirus disease 2019 covid 19 and multidrug resistant bacterial coinfections at an indonesian tertiary hospital
topic coronavirus disease 2019 (covid-19)
pneumonia
respiratory tract infection
multidrug-resistant organisms (mdros)
tropical disease
url https://e-journal.unair.ac.id/CIMRJ/article/view/53649
work_keys_str_mv AT joedhistirabayufirmansyah profilesofdeceasedpatientswithcoronavirusdisease2019covid19andmultidrugresistantbacterialcoinfectionsatanindonesiantertiaryhospital
AT musofarusli profilesofdeceasedpatientswithcoronavirusdisease2019covid19andmultidrugresistantbacterialcoinfectionsatanindonesiantertiaryhospital
AT juniastuti profilesofdeceasedpatientswithcoronavirusdisease2019covid19andmultidrugresistantbacterialcoinfectionsatanindonesiantertiaryhospital
AT ratnaseptyawati profilesofdeceasedpatientswithcoronavirusdisease2019covid19andmultidrugresistantbacterialcoinfectionsatanindonesiantertiaryhospital